about
Metabolic Imaging in Prostate Cancer: Where We AreDiffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's diseaseImaging brain functional and metabolic changes in restless legs syndrome.Brain magnetic resonance metabolic and microstructural changes in adult-onset autosomal dominant leukodystrophy.Diffusion-weighted imaging study of patients with essential tremor.Visual system involvement in patients with Friedreich's ataxia.Pitfalls and advantages of different strategies for the absolute quantification of N-acetyl aspartate, creatine and choline in white and grey matter by 1H-MRS.Abnormal medial thalamic metabolism in patients with idiopathic restless legs syndrome.Secondary post-geniculate involvement in Leber's hereditary optic neuropathyEnergy metabolism in migraine.Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study.Combined brain voxel-based morphometry and diffusion tensor imaging study in idiopathic restless legs syndrome patients.The effect of diffusion gradient direction number on corticospinal tractography in the human brain: an along-tract analysis.Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up.Relationship of white and gray matter abnormalities to clinical and genetic features in myotonic dystrophy type 1.Cerebral functions and metabolism after antegrade selective cerebral perfusion in aortic arch surgery.Altered cellular metabolism following traumatic brain injury: a magnetic resonance spectroscopy study.Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich's ataxia.Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease.Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.Quantitative proton magnetic resonance spectroscopy of the cervical spinal cord.Low brain iron content in idiopathic restless legs syndrome patients detected by phase imaging.High-dose creatine therapy for Huntington disease: a 2-year clinical and MRS study.Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy.Effects of exercise-induced intracellular acidosis on the phosphocreatine recovery kinetics: a 31P MRS study in three muscle groups in humans.Distribution of neurochemical abnormalities in patients with narcolepsy with cataplexy: An in vivo brain proton MR spectroscopy study.Cytosolic pH buffering during exercise and recovery in skeletal muscle of patients with McArdle's disease.Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle's disease.Multi-class parkinsonian disorders classification with quantitative MR markers and graph-based features using support vector machines.Cerebral Mitochondrial Microangiopathy Leads to Leukoencephalopathy in Mitochondrial Neurogastrointestinal Encephalopathy.Precuneal Thickness and Depression in Parkinson Disease.Thalamic contribution to Sleep Slow Oscillation features in humans: a single case cross sectional EEG study in Fatal Familial Insomnia.Diffusion tensor MRI changes in cerebellar structures of patients with familial essential tremor.White matter and cortical changes in atypical parkinsonisms: A multimodal quantitative MR study.Diffusion Tensor Imaging Mapping of Brain White Matter Pathology in Mitochondrial Optic Neuropathies.Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.Voxel-based morphometry to detect effect of APOE on brain gray matter changes in Parkinson's Disease.Combined Cerebellar Proton MR Spectroscopy and DWI Study of Patients with Friedreich's Ataxia.Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
P50
Q28074429-8F2F6C81-3EF7-4C0A-A69D-0663804A0567Q28295298-F91576CC-C9B8-4BFC-BD6C-6122CDE22938Q30656967-161EC85B-AEAC-447C-85F5-3A59DE7231C5Q30981396-AF0DB271-B8E7-4C7D-8F42-F4C920651394Q31110931-C98DB92E-5427-43E7-A294-46A3B5AA50A8Q33377900-600397B4-B42D-46C3-ABC8-53B9C3A2A021Q33463544-571991DB-A591-45C3-A3E9-1C9151048BECQ34489088-F6ED2351-7F6B-4E65-AC98-87BDC3721A4BQ34500034-8327236B-669F-4FDC-B954-3F7D95AF4CADQ36475097-03982FFB-983C-4B4B-AAD5-36BDC6198AA0Q37005403-415F82E6-5BA4-48A5-BCA5-703144CC7B9AQ37381065-760740B4-777A-400E-BF73-A2B067022B7EQ37969177-C7B8462B-915D-4FFA-B62D-28AC0A5E3B94Q39079402-5C473D29-9CC8-4432-B23D-FCBAC1DFE235Q42653222-E1758062-31F7-43F1-842A-44917A3E8403Q42735877-586A409A-2A4D-48FF-8CFA-FA7D6B3C84F8Q43170409-814D9F85-BF26-49BA-8587-7AEABEE5DB0CQ43563600-0B77A42B-0E33-4E07-95FE-AA66CF8297ADQ43611551-F67E2821-A3E7-46BD-AFE2-35F00BF91A5EQ43899144-25226063-441A-4125-AE5E-6397A67BA756Q44480693-F1755059-E4C8-42C1-AFF3-52F867A4BEB3Q44916226-5BB6B98B-5751-4A13-88D3-A1F688C4D3E2Q45201265-CBBA7A58-63C8-4224-A194-B1EC14240B23Q45296832-D21103F7-0635-4ACA-8AEA-220252EE5FD3Q45300771-B1100F22-1729-4CBF-AF1A-B4D37E280976Q45835291-3EE421D2-9067-4D8D-83A5-59FA96BCC968Q45999781-4B433D92-1929-426D-99F2-6EACC4EB1951Q46208219-0E568B00-2324-4F9A-9237-6EB28A1538BCQ46837332-E4B997C0-9363-473A-801C-51116004E462Q47363688-3BA37C57-A148-4CC8-B835-4197BBBF2C8DQ47710646-CC2FE89A-BB99-4438-BDE3-D3D0638AB5F4Q48027908-D8012847-076D-46FA-814B-B5FD82E4F4D1Q48243880-921CA41C-1826-4ADC-812D-5B53997C9857Q48263554-3F2A65F1-2507-4378-A7F9-E32AD5CCB7A6Q48264442-EC036F8C-9B91-447E-83AE-44A86FD4A078Q48270984-AC6F1DD5-212B-4A4D-B216-D8EB36C06E13Q48481133-0B8EA444-1C3E-4441-AE78-E8627E892424Q48592887-1E2B80A3-B9BB-48E9-AF6A-94DB460BF5CFQ48863338-7BB40D9C-A298-4842-92C2-5A4FF3F4C3F2Q48909642-4344C9C2-55FD-4CA6-9B14-AFFA7FACD4D8
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
David Manners
@ast
David Manners
@en
David Manners
@es
David Manners
@nl
David Manners
@sl
type
label
David Manners
@ast
David Manners
@en
David Manners
@es
David Manners
@nl
David Manners
@sl
altLabel
David N. Manners
@en
David Neil Manners
@en
prefLabel
David Manners
@ast
David Manners
@en
David Manners
@es
David Manners
@nl
David Manners
@sl
P1053
J-2415-2012
P106
P1153
7004151863
P21
P31
P3829
P496
0000-0002-2404-1101